DJIA 17,757.91 138.40 0.79%
NASDAQ 5,013.12 26.26 0.53%
S&P 500 2,077.42 14.31 0.69%
market minute promo

Amarin Corp plc (ADR) (NASDAQ: AMRN)

2.45 -0.01 (-0.41%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

AMRN $2.45 -0.41%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.47
Previous Close $2.46
Daily Range $2.40 - $2.53
52-Week Range $0.78 - $3.33
Market Cap $433.9M
P/E Ratio -6.31
Dividend (Yield) $0.00 (0.0%)
Volume 1,413,334
Average Daily Volume 2,489,951
Current FY EPS -$0.53




Drug Makers

Amarin Corp plc (ADR) (AMRN) Description

The Company is engaged in the research, development and commercialization of novel drugs for the treatment of central nervous system disorders. Website:

News & Commentary

3 Biotech Stocks That I Won't Buy

One Motley Fool shares the three biotech stocks he can't justify buying for his portfolio.

European ADRs Ebb as Pharma Stocks Contract

European ADRs Gain Traction as Retail Stocks Surge

European ADRs Slide as Banking Stocks Trade Lower

European ADRs Trade Lower as Pharma Stocks Slide

Amarin Corporation PLC Shares Lifted Off in May -- Here's Why

Amarin gets investors' hearts racing with a favorable legal ruling regarding its lead drug, Vascepa. Find out what this ruling could mean for Amarin and its investors.

Matinas MAT9001 Beats Vascepa In Head-To-Head Trial

European ADRs Trade Lower as Oil Stocks Feel the Pinch

Amarin: 5-Year Vascepa NCE Exclusivity A Boon To Its Post REDUCE-IT Potential

Amarin (AMRN) in Focus: Stock Surges 19% in Session - Tale of the Tape

See More AMRN News...

AMRN's Top Competitors

AMRN $2.45 (-0.41%)
Current stock: AMRN
JNJ $98.47 (1.04%)
Current stock: JNJ
NVS $98.52 (0.18%)
Current stock: NVS
RHHBY $35.14 (0.20%)
Current stock: RHHBY